105
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Extensive Splenic Infarction, Deep Vein Thrombosis and Pulmonary Emboli Complicating Induction Therapy with All-trans-retinoic Acid (ATRA) for Acute Promyelocytic Leukemia

, &
Pages 1433-1437 | Published online: 01 Jul 2009

References

  • Warrel, P.R. Jr., de The, H., Wang, Z.Y. and Degos, L. (1993) "Acute promyelocytic leukemia", N. Engl. J. Med. 329, 177–189.
  • Degos, L., Dombret, H., Chomienne, C., et al. (1995) "All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia", Blood 85, 2643–2653.
  • Fenaux, P., Chomienne, C. and Degos, L. (2001) "All trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia", Semin. Hematol. 38, 13–25.
  • Escudier, S.M., Kantarjian, H.M. and Estey, E.H. (1996) "Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid", Leuk. Lymphoma 20, 435–439.
  • Barbui, T., Finazzi, G. and Falanga, A. (1998) "The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia", Blood 91, 3093–3102.
  • Falanga, A. and Barbui, T. (2001) "Coagulopathy of acute promyelocytic leukemia", Acta Haematol. 106, 43–51.
  • Pogliani, EM., Rossini, F., Casaroli, Maffe, P. and Corneo, G. (1997) "Thrombotic complications in acute promyelocytic leuke-mia during all-trans-retinoic acid therapy", Acta Haematol. 97, 228–230.
  • Hashimoto, S., Koike, T., Tatewaki, W., Seki, Y, Sato, N., Azegami, T., Tsukada, N., Takahashi, H., Kimura, H., Ueno, M., Arakawa, M. and Shibat, A. (1994) "Fatal thromboembolism in acute promyelocytic leukemia during all trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage", Leukemia 8, 1113–1115.
  • Brown, J.E., Olujohungbe, A., Chang, J., Ryder, W.D.J., Morganstern, G.R., Chopra, R. and Scarffe, J.H. (2000) "All-trans retinoic acid (ATRA) and tranexamic acid: a potentially fatal combination in acute promyelocytic leukemia", Br J. Haematol. 110, 1010–1012.
  • Colovic, M., Miljic, P., Colovic, N., Jankovic, G. and Stojkovic, M. (2001) "Reversible portal vein thrombosis complicating induction therapy of acute promyelolocytic leukemia", Thromb. Res. 101, 101–103.
  • Forjaz De Lacerda, J., Alves Do Carmo, J., Lurdes Guerra, M., Geraldes, J. and Forjaz De Lacerda, J.M. (1993) "Multiple thrombosis in acute promyelocytic leukemia after tretinion", Lancet 342, 114–115.
  • Runde, V, Aul, C., Hey11, A. and Schneider, W. (1992) "All-trans retinoic acid: not only a differentiating agent, but also an inducer of thromboembolic events in patients with M3 leukemia", Blood 79, 534–535.
  • Assouline, D., Negrier, C., Coquard, I., Archimbaud, E., Fiere, Bret, M. and Bodnar, D. (1995) "Successful systemic thrombolysis of hepatic vein thrombosis in a patient with promyelocytic leukemia treated with all-trans retinoic acid", Am. J. Haematol. 48, 291–292.
  • Torromeo, C., Latagliata, R., Avvisati, G., Petti, M.C. and Mandelli, F. (1999) "Coronaric thrombotic events in acute promyelocytic leukemia during all-trans retinoic acid treatment: a role for adhesion molecules overexpression?", Leukemia 13, 312–313.
  • Torromeo, C., Latagliata, R., Avvisati, G., Petti, MC. and Mandelli, F. (2001) "Intraventricular thrombosis during all-trans retinoic acid treatment in acute promyelocytic leukemia", Leukemia 15, 1311–1313.
  • Rees, D., Grimwade, D., Langabeer, S., Burnett, A. and Goldstone, A. (1997) "Influence of genetic predisposition to thrombosis on natural history of acute promyelocytic leukemia", Br J. Haematol. 96, 490–492.
  • Fenaux, P., Chastang, C., Chevret, S., et al. (1999) "A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia", Blood 94, 1192–1200.
  • Gillis, S., Dann, E.J. and Eldor, A. (1995) "Low molecular weight heparin in the prophylaxis and treatment of disseminated intravascular coagulation in acute promyelocytic leukemia", Eur. J. Haematol. 54, 59–60.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.